A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Recruiting

Phase 2

Colorectal CancerA Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Sponsor:

AstraZeneca

Code:

NCT06792695

Conditions

Metastatic Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Volrustomig

FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)

Bevacizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-02. This information was provided to ClinicalTrials.gov by AstraZeneca on 2026-05-11.